Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) to Post FY2027 Earnings of $1.01 Per Share, Wedbush Forecasts
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) – Equities research analysts at Wedbush decreased their FY2027 EPS estimates for Ultragenyx Pharmaceutical in a research report issued on Friday, August 2nd. Wedbush analyst L. Chico now expects that the biopharmaceutical company will earn $1.01 per share for the year, down from their prior estimate of $1.04. […]
More Stories
Order of the Sinking Star is Ready to Launch on PlayStation 5 and TV
The creator of Braid and The Witness, Jonathan Blow, is returning with an all-new puzzle video game, Order of the...
Netflix’s Upcoming Drama, All the Truth in My Lies: Release Date, Cast, and More
Excited to know about the upcoming Spanish drama on Netflix, All the Truth in My Lies. If you love watching...
Obsession (2026): Release Date, Cast Members, Trailer, Plot, and More
Be Alert: Spoilers Ahead! Are you also a lover of horror shows and looking for upcoming horror movies and series...
Desire 2026: Release Date, Cast Members, Trailer, Audio, and More
Netflix is expanding its international movie lineup with intense action, thriller, and drama that explore the complexities of human emotions....
AI Assistants Overwhelmingly Cite Third-Party Lists, Not Company Homepages, Study Finds
Artificial intelligence assistants overwhelmingly cite third-party “best-of” and comparison pages rather than companies’ own websites, according to a new study...
How Businesses are Incorporating AI Video Into Sales Processes
Over the last few years, businesses have had to rethink their traditional sales processes. Consumers are more empowered to complete...